SGMO - Sangamo Therapeutics GAAP EPS of -$0.27 misses by $0.05 revenue of $0.48M misses by $5.88M
2024-05-09 16:10:38 ET
More on Sangamo Therapeutics
- Sangamo Therapeutics looks to raise $24M in a direct offering; shares fall
- Sangamo Therapeutics GAAP EPS of -$0.34 misses by $0.08, revenue of $2.04M misses by $6.07M
- Seeking Alpha’s Quant Rating on Sangamo Therapeutics
- Historical earnings data for Sangamo Therapeutics
- Financial information for Sangamo Therapeutics